Trials / Withdrawn
WithdrawnNCT04464577
A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235
A Phase 1, Open-label Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Pharmacokinetics and Safety of BMS-986235
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the effect of inhibitors, at steady state, on the drug levels, safety, and tolerability of BMS-986235 when taken by healthy participants. The inhibitors to be utilized in this study are fluconazole, bupropion, and itraconazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluconazole | Specified Dose on Specified Days |
| DRUG | Bupropion | Specified Dose on Specified Days |
| DRUG | Itraconazole | Specified Dose on Specified Days |
| DRUG | BMS-986235 | Specified Dose on Specified Days |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-06-07
- Completion
- 2021-06-08
- First posted
- 2020-07-09
- Last updated
- 2022-03-25
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04464577. Inclusion in this directory is not an endorsement.